GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Assertio Holdings Inc (FRA:DPOA) » Definitions » Total Operating Expense

Assertio Holdings (FRA:DPOA) Total Operating Expense : €102.4 Mil (TTM As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Assertio Holdings Total Operating Expense?

Assertio Holdings's Total Operating Expense for the three months ended in Mar. 2024 was €22.9 Mil. Assertio Holdings's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was €102.4 Mil.

Assertio Holdings Total Operating Expense Historical Data

The historical data trend for Assertio Holdings's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Assertio Holdings Total Operating Expense Chart

Assertio Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 198.67 109.59 71.47 74.95 99.96

Assertio Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.66 21.74 30.46 27.29 22.90

Assertio Holdings Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €102.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Assertio Holdings Total Operating Expense Related Terms

Thank you for viewing the detailed overview of Assertio Holdings's Total Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Assertio Holdings (FRA:DPOA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Assertio Holdings Inc (FRA:DPOA) » Definitions » Total Operating Expense
Comparable Companies
ETON MRMD SCYX BKUH TKNO DERM SSIC ETST RGC OPTN XTER:MRK ZTS NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ NBIX SZSE:000538 NSE:DIVISLAB
Traded in Other Exchanges
ASRT:USA
Address
100 South Saunders Road, Suite 300, Lake Forest, IL, USA, 60045
Website
https://www.assertiotx.com
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults 18 years of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

Assertio Holdings (FRA:DPOA) Headlines

No Headlines